Novel indazolylpyrazolo[1,5-a]pyrimidine analogues have been prepared and found to be extremely potent type I B-Raf inhibitors. The lead compound shows good selectivity against a panel of 60 kinases, possesses a desirable pharmacokinetic profile, and demonstrates excellent in vivo antitumor efficacy in B-Raf mutant xenograft models.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jm1007566 | DOI Listing |
Publication Analysis
Top Keywords
b-raf inhibitors
8
indazolylpyrazolopyrimidine highly
4
highly potent
4
potent b-raf
4
inhibitors vivo
4
vivo activity
4
activity novel
4
novel indazolylpyrazolo[15-a]pyrimidine
4
indazolylpyrazolo[15-a]pyrimidine analogues
4
analogues prepared
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!